Boston Heart Lab Corp. closed a $10 million funding round, according to a Securities & Exchange Commission filing.
The Framingham, Mass.-based heart disease test maker began the sale of equity and options July 26.
According to the filing, a total of 46 investors were involved in the round. The document names former Cequent Pharmaceuticals Inc. CEO and current Boston Heart Lab chairman Peter Parker as a director, while Jeff Crisan and Alice Limkakeng of Boston-based Bain Capital Ventures are also named as directors.
Boston Heart Lab‘s CEO is Susan Hertzberg, a former Quest Diagnostics executive, according to its website.